CMS Announces Proposed Rule on Medicare Part D and Medicaid Prescription Drug Programs

View in browser | Distributed by Center for Medicaid and CHIP Services (CMCS)     CMS Announces Proposed Rule on Medicare Part D and Medicaid Prescription Drug Programs Today, CMS announced the proposed rule Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-P). Among other provisions, the proposed rule includes a proposal for the coverage of anti-obesity medications for the treatment of obesity in Medicare and Medicaid. The proposed rule also includes other provisions that would impact Medicaid programs, including provisions related to new federal requirements for dual-eligible special needs plans.  The proposed rule can be viewed on the Federal Register.  A fact sheet with additional details on the proposed changes can be viewed on CMS.gov.  Stay connected with Medicaid.gov and CMS: Modify/Update Subscriber Preferences  |  Unsubscribe  |  Contact Us   Questions or problems? Please contact subscriberhelp.govdelivery.com. This e-mail was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of the Centers for Medicare & Medicaid Services (410-786-5473) · 7500 Security Boulevard · Baltimore MD 21244